TRANSITION and Separation AGREEMENT and release of claimsTransition and Separation Agreement • August 2nd, 2022 • Phathom Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
This Transition and Separation Agreement and Release of Claims (the “Agreement”) is entered into by and among Anthony Guzzo (“Executive”) and Phathom Pharmaceuticals, Inc. (the “Company”).
CONSENT AND FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT THIS CONSENT AND FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (thisLoan and Security Agreement • August 2nd, 2022 • Phathom Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Revenue Interest Financing Agreement By and Among Phathom Pharmaceuticals, Inc., as the Company and The Entities Set Forth on Schedule 1.1, as Investors Dated as of May 3, 2022Revenue Interest Financing Agreement • August 2nd, 2022 • Phathom Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This REVENUE INTEREST FINANCING AGREEMENT, dated as of May 3, 2022 (this “Agreement”), is made and entered into by and among Phathom Pharmaceuticals, Inc., a Delaware corporation (the “Company”), the entities set forth on Schedule 1.1 hereto (the “Initial Investors”) and any other entity or entities that become party hereto pursuant to Section 2.1(b)(ii) or Section 2.1(c) (together with the Initial Investors, the “Investors”, and each, individually, an “Investor”).
